Acuitas Investments »

Adaptimmune Therapeutics shares owned by Acuitas Investments

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Acuitas Investments from 13F filings

Historical chart of Acuitas Investments investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Acuitas Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Acuitas Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $381k 480k 0.79
2023-09-30 $374k 480k 0.78